Market Currents

• Tuesday, January 13, 2009

• 09:02 AM ZymoGenetics (ZGEN) +59% premarket after Bristol-Myers (BMY) pays $85M for its experimental hepatitis C treatment up front, and could pay as much as $1.1B based on future milestones. 1 Comment
• 09:00 AM Premarket gainers: ZGEN +59%. FCEL +15%. ELN +13%. LIZ +8%. YRCW +8%. HOGS +6%. INFY +5%. GERN +5%. DNDN +5%. Comment!